Analyzing the publicly available dataset GSE94669, we could also notice that even though CD44 is a known marker for ABC DLBCL classification [83], CD44 levels are consistently higher in lymphoma cell lines expressing mutated MyD88. This evidence concerns the gene CD44 and aneurysmal bone cyst.